On 5-6 October 2000 CONCEPT HEIDELBERG in cooperation with the European Compliance Academy (ECA) organised a conference where current FDA requirements of 21 CFR Part 11 1 were discussed.
The following Questions and Answers come from the Panel Discussion and were put together by one of the most famous expertsin this field, Dr. Ludwig Huber (Hewlett Packard).
During the period from September 6 - 8, 2000 the 3rd European GMP Conference on Active Pharmaceutical Ingredients of APIC, a subgroup CEFIC, took place in Hamburg.